Home Corium

Corium

acquired
IPO Delisting
Developer of Central Nervous System Health Therapies
Basic
Enterprise Profile

Basic Information

Corium is a commercial-stage biopharmaceutical company leading the development and commercialization of therapies for central nervous system care, providing important treatment options for clinicians, patients and their families, and caregivers.
Corium Inc.
Cambridge,Massachusetts,United States of America
more than 500 people
January 01, 1995
--

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Gene Technology Biotechnology
Application Scenarios
Biologics